Farnesiferol B and Kamolonol Isolated from Ferula assa-foetida are Potent BACE1 Inhibitors with Neuroprotective Effects

Abstract

Five compounds were isolated from Ferula assa-foetida and their beta-secretase 1 inhibitory activities were evaluated. Farnesiferol B and kamolonol showed potent beta-secretase 1 inhibitory activity with IC₅₀ values of 8.11 and 1.00 µM and competitive inhibition patterns against beta-secretase 1 with K_i values of 6.51 and 0.41 µM, respectively. In silico pharmacokinetics showed that farnesiferol B was predicted to have high gastrointestinal absorption and blood-brain barrier permeability. In cell studies, farnesiferol B and kamolonol were nontoxic to normal Madin-Darby canine kidney and neuroblastoma cells, and both showed protective effects on neuroblastoma cells for Aβ₄₂-induced neurotoxicity. In molecular docking simulations, we found that the efficacy of the compounds may be related to their interaction with the flap region and hydrogen bonding with ARG368. In addition, molecular dynamics simulation of kamolonol showed the ligand maintained its stability in interaction with the loop residues. These results show that farnesiferol B and kamolonol are potent beta-secretase 1 inhibitors with neuroprotective effects, suggesting that they are potential candidates for the treatment of neurodegenerative disorders, such as Alzheimerʼs disease.

Keywords

Apiaceae - Ferula assa-foetida - farnesiferol B - kamolonol - potent beta-secretase 1 inhibitory activity - kinetics - docking simulation - molecular dynamics - cell study

Publication History

Received: 13 April 2025

Accepted after revision: 14 August 2025

Accepted Manuscript online:
25 August 2025

Article published online:
11 September 2025

• References

• 1 Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease. Nat Rev Dis Primers 2021; 7: 33
• 2 2024 Alzheimerʼs disease facts and figures. Alzheimers Dement 2024; 20: 3708-3821
• 3 Long S, Benoist C, Weidner W. World Alzheimer report 2023. Reducing dementia risk: Never too early, never too late. Alzheimers Dis Int 2023; 2025. Accessed June 16, 2025 at: https://www.alzint.org/u/World-Alzheimer-Report-2023.pdf
• 4 Atri A. The Alzheimerʼs disease clinical spectrum: Diagnosis and management. Med Clin North Am 2019; 2: 103
• 5 Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M, Slomkowski M, Baker RA, McQuade RD, Cummings JL. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimerʼs dementia: Two 12-week, randomized, double-blind, placebo-controlled trials. Am J Geriatr Psychiatry 2020; 28: 383-400
• 6 Ghosh AK, Osswald HL. BACE1 (β-Secretase) inhibitors for the treatment of Alzheimerʼs disease. Chem Soc Rev 2014; 43: 6765-6813
• 7 Özdemir Z, Alagöz MA, Bahçecioğlu ÖF, Gök S. Monoamine oxidase-B (MAO-B) inhibitors in the treatment of Alzheimerʼs and Parkinsonʼs disease. Curr Med Chem 2021; 28: 6045-6065
• 8 Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimerʼs disease: Targeting the cholinergic system. Curr Neuropharmacol 2016; 14: 101-115
• 9 Chowdhury S, Kumar S. Inhibition of BACE1, MAO‐B, cholinesterase enzymes, and anti‐amyloidogenic potential of selected natural phytoconstituents: multi‐target‐directed ligand approach. J Food Biochem 2021; 45: e13571
• 10 Kuk EB, Jo AR, Oh SI, Sohn HS, Seong SH, Roy A, Choi JS, Jung HA. Anti-Alzheimerʼs disease activity of compounds from the root bark of Morus Alba L. Arch Pharm Res 2017; 40: 338-349
• 11 Lv L, Yang QY, Zhao Y, Yao CS, Sun Y, Yang EJ, Song KS, Mook-Jung I, Fang WS. BACE1 (β-Secretase) inhibitory chromone glycosides from Aloe Vera and Aloe Nobilis . Planta Med 2008; 74: 540-545
• 12 Jung HA, Ali Y, Jung HJ, Jeong HO, Chung HY, Choi JS. Inhibitory activities of major anthraquinones and other constituents from Cassia Obtusifolia against β-Secretase and cholinesterases. J Ethnopharmacol 2016; 191: 152-160
• 13 Akbarian A, Rahimmalek M, Sabzalian MR, Hodaei M. Sequencing and phylogenetic analysis of phenylalanine ammonia lyase (pal) and chalcone synthase (chs) genes in some iranian endemic species of Apiaceae . Gene Rep 2021; 23: 101147
• 14 Niazmand R, Razavizadeh BM. Ferula Asafoetida: Chemical composition, thermal behavior, antioxidant and antimicrobial activities of leaf and gum hydroalcoholic extracts. J Food Sci Technol 2021; 58: 2148-2159
• 15 Srinivasan K. Spices as influencers of body metabolism: An overview of three decades of research. Food Res Int 2005; 38: 77-86
• 16 Appendino G, Maxia L, Bascope M, Houghton PJ, Sanchez-Duffhues G, Muñoz E, Sterner OA. Meroterpenoid NF-κB inhibitor and drimane sesquiterpenoids from Asafetida . J Nat Prod 2006; 69: 1101-1104
• 17 Gholamnejad Z, Byrami G, Boskabady MH, Iranshahi M. Possible mechanism(s) of the relaxant effect of asafoetida (Ferula Assa-foetida) oleo-gum-resin extract on guinea-pig tracheal smooth muscle. Avicenna J Phytomed 2012; 2: 10-16
• 18 Fatehi M, Farifteh F, Fatehi-Hassanabad Z. Antispasmodic and hypotensive effects of Ferula Asafoetida gum extract. J Ethnopharmacol 2004; 91: 321-324
• 19 Sirizi MAG, Alizadeh Ghalenoei J, Allahtavakoli M, Forouzanfar H, Bagheri SM. Anticancer potential of Ferula Assa-foetida and its constituents, a powerful plant for cancer therapy. World J Biol Chem 2023; 14: 28-39
• 20 Beladjal H, Bouhadi D, Belkhodja H. HPLC-DAD Analysis and antioxidant potential of Ferula Assa Foetida resin ethanol extract. Trop J Nat Prod Res 2024; 8: 6906-6910
• 21 Jalili B, Saeidi-sar S, Masoudian N, Zarban A, Namaei MH. Variability in phenolic compounds, antioxidant capacity and essential oil profile in different tissues of Ferula Assa-Foetida L. populations in Iran: an opportunity for industrial products. Plant Genet Resour 2024; 22: 97-106
• 22 Bagheri SM, Hedesh ST, Mirjalili A, Dashti-R MH. Evaluation of anti-inflammatory and some possible mechanisms of antinociceptive effect of Ferula Assa Foetida oleo gum resin. J Evid Based Complementary Altern Med 2016; 21: 271-276
• 23 Unnikrishnan MC, Kuttan R. Tumour reducing and anticarcinogenic activity of selected spices. Cancer Lett 1990; 51: 85-89
• 24 Kanani MR, Rahiminejad MR, Sonboli A, Mozaffarian V, Kazempour Osaloo S, Nejad Ebrahimi S. Chemotaxonomic significance of the essential oils of 18 Ferula Species (Apiaceae) from Iran. Chem Biodivers 2011; 8: 503-517
• 25 Naushad M, Durairajan SSK, Bera AK, Senapati S, Li M. Natural compounds with anti-BACE1 activity as promising therapeutic drugs for treating Alzheimerʼs disease. Planta Med 2019; 85: 1316-1325
• 26 Jung HA, Ali Y, Jung HJ, Jeong HO, Chung HY, Choi JS. Inhibitory activities of major anthraquinones and other constituents from Cassia Obtusifolia against β-Secretase and cholinesterases. J Ethnopharmacol 2016; 191: 152-160
• 27 Youn K, Jun M. Biological evaluation and docking analysis of potent BACE1 inhibitors from Boesenbergia Rotunda . Nutrients 2019; 11: 662
• 28 Qi C, Bao J, Wang J, Zhu H, Xue Y, Wang X, Li H, Sun W, Gao W, Lai Y, Chen JG, Zhang Y. Asperterpenes A and B, two unprecedented meroterpenoids from Aspergillus Terreus with BACE1 inhibitory activities. Chem Sci 2016; 7: 6563-6572
• 29 Youn K, Park JH, Lee S, Lee S, Lee J, Yun EY, Jeong WS, Jun M. BACE1 inhibition by genistein: Biological evaluation, kinetic analysis, and molecular docking simulation. J Med Food 2018; 21: 416-420
• 30 Dastan D, Salehi P, Ghanati F, Gohari AR, Maroofi H, Alnajar N. Phytotoxicity and cytotoxicity of disesquiterpene and sesquiterpene coumarins from Ferula Pseudalliacea . Ind Crops Prod 2014; 55: 43-48
• 31 Mahaki H, Tanzadehpanah H, Abou-Zied OK, Moghadam NH, Bahmani A, Salehzadeh S, Dastan D, Saidijam M. Cytotoxicity and antioxidant activity of kamolonol acetate from Ferula Pseudalliacea, and studying its interactions with calf thymus DNA (Ct-DNA) and human serum albumin (HSA) by spectroscopic and molecular docking techniques. Process Biochem 2019; 79: 203-213
• 32 Kim MS, Oh KS, Lee JH, Ryu SY, Mun J, Lee BH. Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of rho-associated kinase 2 activity. Biochem Biophys Res Commun 2013; 438: 318-323
• 33 Dastan D, Salehi P, Reza Gohari A, Ebrahimi S, Aliahmadi A, Hamburger M. Bioactive sesquiterpene coumarins from Ferula Pseudalliacea . Planta Med 2014; 80: 1118-1123
• 34 Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M. PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 2021; 49: W530-W534
• 35 Wang Y, Yang F, Yan D, Zeng Y, Wei B, Chen J, He W. Identification mechanism of BACE1 on inhibitors probed by using multiple separate molecular dynamics simulations and comparative calculations of binding free energies. Molecules 2023; 28: 4773
• 36 Liu S, Fu R, Cheng X, Chen SP, Zhou LH. Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE). BMC Struct Biol 2012; 12: 21
• 37 Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A. Alzheimerʼs disease: Advances in drug development. J Alzheimers Dis 2018; 65: 3-13
• 38 Ghosh AK, Osswald HL. BACE1 (β-secretase) inhibitors for the treatment of Alzheimerʼs disease. Chem Soc Rev 2014; 43: 6765-6813
• 39 Eketjäll S, Janson J, Kaspersson K, Bogstedt A, Jeppsson F, Fälting J, Haeberlein SB, Kugler AR, Alexander RC, Cebers G. AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics. J Alzheimers Dis 2016; 50: 1109-1123
• 40 Machauer R, Lueoend R, Hurth K, Veenstra SJ, Rueeger H, Voegtle M, Tintelnot-Blomley M, Rondeau JM, Jacobson LH, Laue G, Beltz K, Neumann U. Discovery of Umibecestat (CNP520): A potent, selective, and efficacious β-secretase (BACE1) inhibitor for the prevention of Alzheimerʼs disease. J Med Chem 2021; 64: 15262-15274
• 41 Oh JM, Kim SH, Pandey BP, Shin WH, Son HJ, Kwon YJ, Kim H. A stilbenoid, rhapontigenin, isolated from the root of Rheum palmatum L. acts as a potent BACE1 inhibitor. Fitoterapia 2025; 182: 106484
• 42 Oh JM, Jang HJ, Kang MG, Mun SK, Park D, Hong SJ, Kim MH, Kim SY, Yee ST, Kim H. Medicarpin and homopterocarpin isolated from Canavalia Lineata as potent and competitive reversible inhibitors of human monoamine oxidase-B. Molecules 2022; 28: 258
• 43 Oh JM, Kang Y, Hwang JH, Park JH, Shin WH, Mun SK, Lee JU, Yee ST, Kim H. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B. Int J Biol Macromol 2022; 217: 910-921
• 44 Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2023 update. Nucleic Acids Res 2023; 51: D1373-D1380
• 45 Charrier N, Clarke B, Cutler L, Demont E, Dingwall C, Dunsdon R, East P, Hawkins J, Howes C, Hussain I, Jeffrey P, Maile G, Matico R, Mosley J, Naylor A, OʼBrien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G. Second generation of hydroxyethylamine BACE-1 inhibitors: Optimizing potency and oral bioavailability. J Med Chem 2008; 51: 3313-3317
• 46 Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera–A visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-1612
• 47 Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC. DOCK 6: Impact of new features and current docking performance. J Comput Chem 2015; 36: 1132-5648
• 48 Wang R, Lai L, Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput Aided Mol Des 2002; 16: 11-26
• 49 Lee J, Cheng X, Swails JM, Yeom MS, Eastman PK, Lemkul JA, Wei S, Buckner J, Jeong JC, Qi Y, Jo S, Pande VS, Case DA, Brooks 3rd CL, MacKerell jr. AD, Klauda JB, Im W. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 2016; 12: 405-413
• 50 Oh JM, Park JE, Mun SK, Yee ST, Kim H. Ameliorative effect of medicarpin on scopolamine-induced cognitive impairment in mice. Processes 2023; 11: 385